Ad is loading...
INSM
Price
$73.44
Change
-$0.37 (-0.50%)
Updated
Nov 22, 03:26 PM (EDT)
90 days until earnings call
OBIO
Price
$5.65
Change
+$0.21 (+3.86%)
Updated
Nov 22, 03:16 PM (EDT)
Ad is loading...

INSM vs OBIO

Header iconINSM vs OBIO Comparison
Open Charts INSM vs OBIOBanner chart's image
Insmed
Price$73.44
Change-$0.37 (-0.50%)
Volume$278
CapitalizationN/A
Orchestra BioMed Holdings
Price$5.65
Change+$0.21 (+3.86%)
Volume$100
CapitalizationN/A
INSM vs OBIO Comparison Chart
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INSM vs. OBIO commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a StrongBuy and OBIO is a Buy.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (INSM: $73.81 vs. OBIO: $5.44)
Brand notoriety: INSM and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 89% vs. OBIO: 66%
Market capitalization -- INSM: $13B vs. OBIO: $205.77M
INSM [@Biotechnology] is valued at $13B. OBIO’s [@Biotechnology] market capitalization is $205.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, INSM is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 5 TA indicator(s) are bullish while OBIO’s TA Score has 5 bullish TA indicator(s).

  • INSM’s TA Score: 5 bullish, 4 bearish.
  • OBIO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both INSM and OBIO are a good buy in the short-term.

Price Growth

INSM (@Biotechnology) experienced а +3.58% price change this week, while OBIO (@Biotechnology) price change was -12.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.00%.

Reported Earning Dates

INSM is expected to report earnings on Feb 20, 2025.

OBIO is expected to report earnings on Jan 25, 2023.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($13B) has a higher market cap than OBIO($206M). INSM YTD gains are higher at: 138.174 vs. OBIO (-40.416). OBIO has higher annual earnings (EBITDA): -59.81M vs. INSM (-769.56M). INSM has more cash in the bank: 1.47B vs. OBIO (66.9M). OBIO has less debt than INSM: OBIO (1.84M) vs INSM (1B). INSM has higher revenues than OBIO: INSM (343M) vs OBIO (2.65M).
INSMOBIOINSM / OBIO
Capitalization13B206M6,311%
EBITDA-769.56M-59.81M1,287%
Gain YTD138.174-40.416-342%
P/E RatioN/AN/A-
Revenue343M2.65M12,958%
Total Cash1.47B66.9M2,194%
Total Debt1B1.84M54,407%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMOBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
48%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 11 days ago
73%
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
DOCK.X0.0022950.000210
+10.06%
Dock cryptocurrency
QTUM.X3.2776940.296666
+9.95%
Qtum cryptocurrency
STX.X1.9275890.117872
+6.51%
Stacks cryptocurrency
DEGO.X2.1377350.081451
+3.96%
Dego Finance cryptocurrency
STRAX.X0.0573120.001088
+1.93%
Stratis [New] cryptocurrency

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+1.57%
THAR - INSM
74%
Closely correlated
+4.40%
AGIO - INSM
44%
Loosely correlated
+1.68%
SRPT - INSM
44%
Loosely correlated
-0.32%
VERA - INSM
41%
Loosely correlated
+2.80%
AXON - INSM
40%
Loosely correlated
+3.52%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with AURA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+3.03%
AURA - OBIO
36%
Loosely correlated
+3.20%
INSM - OBIO
35%
Loosely correlated
+1.57%
CALC - OBIO
33%
Poorly correlated
N/A
PGEN - OBIO
32%
Poorly correlated
+7.91%
ALDX - OBIO
30%
Poorly correlated
+1.05%
More